IL17A and Alzheimer disease: Additionally, Aβ secreted by the pathogens induces the release of pro-inflammatory cytokines such as interleukin IL-17A and IL-22, and these cytokines can cross the blood brain barrier (BBB), trigger immune activity, and participate in chronic neurodegenerative disease such as AD [32].